ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Yi Liu
Matched on ORCID iD 0000-0001-9748-0650; OpenAlex author ID A5100330475. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- PPARδ: An underappreciated tumor accelerator in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2026.218385↗
- CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-25-1201↗
- Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Co-author DOI 10.1007/s10620-023-07931-3↗
- Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice Co-author DOI 10.1101/2020.12.04.412320↗
- Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41422-019-0195-y↗
- Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. Co-author DOI 10.1093/carcin/bgt004↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daoyan Wei · 4 shared papers, 2020–2026 · strength 0.94
- Paper PPARδ: An underappreciated tumor accelerator in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218385↗
- Paper CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-25-1201↗
- Paper Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of … DOI 10.1007/s10620-023-07931-3↗
- Xiangsheng Zuo · 4 shared papers, 2020–2026 · strength 0.94
- Paper PPARδ: An underappreciated tumor accelerator in pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2026.218385↗
- Paper CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer. DOI 10.1158/1078-0432.ccr-25-1201↗
- Paper Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of … DOI 10.1007/s10620-023-07931-3↗
- Liang Wang · 2 shared papers, 2023–2025 · strength 0.49
- Robert S. Bresalier · 2 shared papers, 2023–2025 · strength 0.49
- Imad Shureiqi · 2 shared papers, 2020–2026 · strength 0.45
- James C. Yao · 2 shared papers, 2020–2026 · strength 0.45
- Danping Niu · 1 shared paper, 2026 · strength 0.36
- Xiling Shen · 1 shared paper, 2025 · strength 0.30
- Peiying Yang · 1 shared paper, 2023 · strength 0.18
- Huamin Wang · 1 shared paper, 2020 · strength 0.09
- Xiaofeng Zheng · 1 shared paper, 2020 · strength 0.09
- Baoan Ji · 1 shared paper, 2020 · strength 0.09
- Donghui Li · 1 shared paper, 2020 · strength 0.09
- Yusheng Chen · 1 shared paper, 2019 · strength 0.07
- Quan Liao · 1 shared paper, 2019 · strength 0.07
- Wenze Wang · 1 shared paper, 2019 · strength 0.07
- Hao Chen · 1 shared paper, 2019 · strength 0.07
- Junya Peng · 1 shared paper, 2019 · strength 0.07
- Menghua Dai · 1 shared paper, 2019 · strength 0.07
- Taiping Zhang · 1 shared paper, 2019 · strength 0.07
- Wenming Wu · 1 shared paper, 2019 · strength 0.07
- Yupei Zhao · 1 shared paper, 2019 · strength 0.07
- Junchao Guo · 1 shared paper, 2019 · strength 0.07
- Chaohui Zuo · 1 shared paper, 2013 · strength 0.02
- Xu Che · 1 shared paper, 2013 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.